• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Efficacy of certolizumab pegol: a case study in a patient with rheumatoid arthritis on maintenance hemodialysis.

作者信息

Nishimura Akito, Minegishi Yohjiroh, Kwamura Keiko, Ichino Asako, Uchiyama Katsufumi

机构信息

Shizuoka P.W.F.A.C Shimizu-Kosei Hospital, Iharacho 578-1, Shimizu-ku, Shizuoka, Shizuoka, 424-0114, Japan,

出版信息

Rheumatol Int. 2015 Sep;35(9):1601-2. doi: 10.1007/s00296-015-3225-1. Epub 2015 Feb 3.

DOI:10.1007/s00296-015-3225-1
PMID:25645901
Abstract
摘要

相似文献

1
Efficacy of certolizumab pegol: a case study in a patient with rheumatoid arthritis on maintenance hemodialysis.聚乙二醇化赛妥珠单抗的疗效：一名维持性血液透析类风湿关节炎患者的病例研究
Rheumatol Int. 2015 Sep;35(9):1601-2. doi: 10.1007/s00296-015-3225-1. Epub 2015 Feb 3.
2
Acute exacerbation of rheumatoid interstitial lung disease during the maintenance therapy with certolizumab pegol.在用聚乙二醇化赛妥珠单抗维持治疗期间类风湿性间质性肺病的急性加重
Mod Rheumatol. 2017 Nov;27(6):1079-1082. doi: 10.3109/14397595.2015.1059008. Epub 2015 Jul 20.
3
Cutaneous leishmaniasis mimicking dactylitis in a patient with rheumatoid arthritis treated with certolizumab.在用赛妥珠单抗治疗的类风湿关节炎患者中出现类似指炎的皮肤利什曼病。
Clin Exp Dermatol. 2018 Apr;43(3):348-350. doi: 10.1111/ced.13307. Epub 2017 Dec 8.
4
Certolizumab pegol was effective for treating residual synovitis after total knee arthroplasty in a patient with rheumatoid arthritis: therapeutic monitoring by ultrasound.赛妥珠单抗聚乙二醇化对类风湿关节炎患者全膝关节置换术后残留滑膜炎有效：超声治疗监测
J Med Ultrason (2001). 2018 Apr;45(2):371-374. doi: 10.1007/s10396-017-0806-5. Epub 2017 Jul 19.
5
A Case of Minimal Change Disease in a Patient with Rheumatoid Arthritis Treated with Certolizumab.1例类风湿关节炎患者使用赛妥珠单抗治疗后发生微小病变病的病例
J Rheumatol. 2019 Dec;46(12):1647. doi: 10.3899/jrheum.190197. Epub 2019 Nov 1.
6
Certolizumab Pegol: A Review in Inflammatory Autoimmune Diseases.聚乙二醇化赛妥珠单抗：炎症性自身免疫性疾病综述
BioDrugs. 2016 Dec;30(6):607-617. doi: 10.1007/s40259-016-0197-y.
7
[Miller Fisher syndrome following treatment with certolizumab in a patient with rheumatoid arthritis].[类风湿关节炎患者使用赛妥珠单抗治疗后出现米勒-费雪综合征]
Rev Neurol. 2017 Sep 16;65(6):286-288.
8
Modeling of the clinical and economic impact of a risk-sharing agreement supporting a treat-to-target strategy in the management of patients with rheumatoid arthritis in France.法国类风湿关节炎患者管理中支持达标治疗策略的风险分担协议的临床和经济影响建模
J Med Econ. 2016 Aug;19(8):812-21. doi: 10.1080/13696998.2016.1176576. Epub 2016 Apr 25.
9
Certolizumab pegol plus methotrexate 5-year results from the rheumatoid arthritis prevention of structural damage (RAPID) 2 randomized controlled trial and long-term extension in rheumatoid arthritis patients.赛妥珠单抗聚乙二醇化制剂联合甲氨蝶呤治疗类风湿关节炎预防结构损伤（RAPID）2随机对照试验的5年结果及类风湿关节炎患者的长期扩展研究
Arthritis Res Ther. 2015 Sep 10;17(1):245. doi: 10.1186/s13075-015-0767-2.
10
Twenty-eight-week results from the REALISTIC phase IIIb randomized trial: efficacy, safety and predictability of response to certolizumab pegol in a diverse rheumatoid arthritis population.IIIb期现实随机试验的28周结果：在不同类风湿性关节炎人群中，赛妥珠单抗的疗效、安全性及反应可预测性
Arthritis Res Ther. 2015 Nov 15;17:325. doi: 10.1186/s13075-015-0841-9.

引用本文的文献

1
Efficacy of peficitinib in two patients with rheumatoid arthritis on maintenance hemodialysis.培非替尼对两名维持性血液透析类风湿关节炎患者的疗效。
J Rural Med. 2022 Jul;17(3):193-195. doi: 10.2185/jrm.2022-005. Epub 2022 Jul 1.

本文引用的文献

1
Efficacy and safety of certolizumab pegol without methotrexate co-administration in Japanese patients with active rheumatoid arthritis: the HIKARI randomized, placebo-controlled trial.聚乙二醇化赛妥珠单抗单药治疗日本活动性类风湿关节炎患者的疗效和安全性：HIKARI随机、安慰剂对照试验
Mod Rheumatol. 2014 Jul;24(4):552-60. doi: 10.3109/14397595.2013.843764. Epub 2013 Nov 1.
2
Effective and safe administration of tocilizumab to a patient with rheumatoid arthritis on haemodialysis.对一名类风湿性关节炎血液透析患者有效且安全地使用托珠单抗。
Rheumatol Int. 2011 Apr;31(4):559-60. doi: 10.1007/s00296-010-1430-5. Epub 2010 Mar 25.
3
Use of etanercept in a patient with rheumatoid arthritis on hemodialysis.
依那西普在一名接受血液透析的类风湿性关节炎患者中的应用。
Mod Rheumatol. 2008;18(3):293-5. doi: 10.1007/s10165-008-0041-4. Epub 2008 Feb 27.
4
Therapeutic effect of the combination of etanercept and methotrexate compared with each treatment alone in patients with rheumatoid arthritis: double-blind randomised controlled trial.与单药治疗相比，依那西普与甲氨蝶呤联合治疗类风湿关节炎患者的疗效：双盲随机对照试验
Lancet. 2004 Feb 28;363(9410):675-81. doi: 10.1016/S0140-6736(04)15640-7.
5
Etanercept versus etanercept plus methotrexate: a registry-based study suggesting that the combination is clinically more efficacious.依那西普单药治疗与依那西普联合甲氨蝶呤治疗：一项基于注册登记的研究表明联合治疗在临床上更有效。
Arthritis Res Ther. 2003;5(6):R347-51. doi: 10.1186/ar1005. Epub 2003 Oct 1.
6
Infliximab treatment in a patient with rheumatoid arthritis on hemodialysis.英夫利昔单抗治疗一名接受血液透析的类风湿关节炎患者。
J Rheumatol. 2002 Mar;29(3):636-7.
7
Severe pancytopenia caused by a single administration of low dose methotrexate in a patient undergoing hemodialysis.一名正在接受血液透析的患者单次服用低剂量甲氨蝶呤后出现严重全血细胞减少。
J Rheumatol. 1999 Jun;26(6):1424-5.